AtriCure (ATRC) Cash from Investing Activities (2010 - 2026)

AtriCure (ATRC) has 17 years of Cash from Investing Activities data on file, last reported at -$3.9 million in Q1 2026.

• Cash from Investing Activities for Q1 2026 came in at -$3.9 million, down 129.15% year-over-year; the trailing twelve-month figure through Mar 2026 was -$16.7 million (down 188.43% YoY), and the FY2025 annual result was -$14.6 million, down 148.12% from the prior year.
• Cash from Investing Activities declined to -$3.9 million in Q1 2026 per ATRC's latest filing, from -$2.6 million in the prior quarter.
• Over five years, Cash from Investing Activities peaked at $30.9 million in Q2 2024 and troughed at -$16.1 million in Q2 2023.
• A 5-year average of $4.6 million and a median of -$1.7 million in 2025 frame the typical range for Cash from Investing Activities.
• The sharpest annual moves came in 2022 and 2024: Cash from Investing Activities soared 550.14% in 2022, then plunged 427.39% in 2024.
• A 5-year view of Cash from Investing Activities shows it stood at $7.0 million in 2022, then slumped by 139.79% to -$2.8 million in 2023, then sank by 427.39% to -$14.7 million in 2024, then soared by 82.29% to -$2.6 million in 2025, then plunged by 48.04% to -$3.9 million in 2026.
• Business Quant data shows ATRC's Cash from Investing Activities at -$3.9 million in Q1 2026, -$2.6 million in Q4 2025, and -$2.6 million in Q3 2025.